Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer

K Vyas, M Rathod, MM Patel - Nanomedicine: Nanotechnology, Biology …, 2023 - Elsevier
Oral cancer is a type of cancer that develops in the mouth and is one of the deadliest
malignancies in the world. Currently surgical, radiation therapy, and chemotherapy are most …

Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer's disease

PK Jayaswamy, M Vijaykrishnaraj, P Patil… - Ageing Research …, 2023 - Elsevier
Epidermal growth factor receptor (EGFR) plays a pivotal role in early brain development,
although its expression pattern declines in accordance with the maturation of the active …

Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery

S Bhattacharya, MM Anjum, KK Patel - Drug delivery, 2022 - Taylor & Francis
This study focused on gemcitabine (GTB) delivery of cationic polymeric nanoparticles to treat
ovarian cancer in order to promote effective localized delivery and drug retention during …

[HTML][HTML] The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy

MPS Damasio, CS Nascimento, LM Andrade… - Frontiers in …, 2022 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) encompass a group of complex entities
of tumours affecting the aerodigestive upper tract. The main risk factors are strongly related …

An appraisal of anticancer activity with structure–activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A review

K Haider, S Das, A Joseph… - Drug Development …, 2022 - Wiley Online Library
Cancer is one of the leading causes of death. Globally a huge number of deaths and new
incidences are reported annually. Heterocyclic compounds have been proved to be very …

Annexin A2: The diversity of pathological effects in tumorigenesis and immune response

Y Huang, M Jia, X Yang, H Han, G Hou… - … Journal of Cancer, 2022 - Wiley Online Library
Abstract Annexin A2 (ANXA2) is widely used as a marker in a variety of tumors. By
regulating multiple signal pathways, ANXA2 promotes the epithelial‐mesenchymal …

[HTML][HTML] Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity

C Liang, X Yuan, Z Shen, Y Wang, L Ding - Molecular Therapy-Oncolytics, 2022 - cell.com
Vorolanib (CM082) is a multi-targeted tyrosine kinase receptor inhibitor with a short half-life
and limited tissue accumulation that has been shown to reduce choroidal …

Positron emission tomography molecular imaging‐based cancer phenotyping

C Jin, X Luo, X Li, R Zhou, Y Zhong, Z Xu, C Cui… - Cancer, 2022 - Wiley Online Library
During the past several decades, numerous studies have provided insights into biological
characteristics of cancer cells and identified various hallmarks of cancer acquired in the …

Design, synthesis and Molecular modeling study of certain EGFR inhibitors with a quinazolinone scaffold as anti-hepatocellular carcinoma and Radio-sensitizers

WM Ghorab, SA El-Sebaey, MM Ghorab - Bioorganic Chemistry, 2023 - Elsevier
A set of novel N-substituted-2-((4-oxo-3-phenyl-3, 4-dihydroquinazolin-2-yl) thio) acetamide
3–16 were designed and synthesized from 2-mercapto-3-phenylquinazolinone 2. The …

[HTML][HTML] Guhong injection protects against apoptosis in cerebral ischemia by maintaining cerebral microvasculature and mitochondrial integrity through the PI3K/AKT …

H Zhou, Y He, J Zhu, X Lin, J Chen, C Shao… - Frontiers in …, 2021 - frontiersin.org
Guhong injection (GHI) can be used for the treatment of ischemic stroke. We investigated the
antiapoptotic activity of GHI, its ability to repair the cerebral microvessels and mitochondria …